In 2024, the forecast re-import of syringes to China is valued at $16.694 million. Compared to 2023 figures, precise data is missing, but a clear upward trend is evident from 2024 to 2028, with steady increases each year. The projected year-on-year percentage growth varies as approximately 4.0% yearly from 2024 through 2028, highlighting consistent demand.
The five-year CAGR suggests a robust market, with an average annual growth of around 3.0% to 4.0% until 2028. This indicates sustained interest or need, driven by factors like healthcare expansion or increased vaccination efforts.
Future trends to watch include technological advancements in syringe manufacturing, domestic production capabilities, and regulatory changes which could impact re-importation dynamics significantly.
